UOB Asset Management raises stake in Indonesian subsidiary to 85.71%
Bitget2026/11/03 22:57- UOB's wholly owned subsidiary UOB Asset Management subscribed for 250 million ordinary shares in PT UOB Asset Management Indonesia.
- The rights issue subscription was priced at IDR 100 per share on July 2, 2026.
- The capital injection increased UOB Asset Management's stake in the Indonesian subsidiary from 84.09% to 85.71%.
- Subsidiary Chung Khiaw Realty was dissolved on August 13, 2026, as part of the group's ongoing rationalization.
- The dissolution is not expected to materially affect group earnings for the financial year ending December 31, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
CleanSpark presents fully funded Sandersville project in investor presentation
Forge Nano completes acquisition of HzO
Crypto prices
More
